3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
9
Prostatic Neoplasms, Castration-Resistant
6
Metastatic Castration-resistant Prostate Cancer
2
Pain
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Fractures, Bone
1
Fatigue
1
Castration-resistant Prostate Cancer
1
Bony Metastases From Castrate Refractory Prostate Cancer
1
Bone Neoplasms
1
Bone Metastatic Castration-resistant Prostate Cancer
1
Advanced Prostate Cancer
1
Interventions
radium Ra 223 dichloride
2
Radionuclide Imaging
1
Pluvicto
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Castration-resistant Prostate Cancer
×
radium Ra 223 dichloride
×
Clear all
NCT02141438
2025-10-16
REASSURE
Bayer
Completed
1,472 enrolled
18 charts
NCT05301062
2023-09-22
CREDIT
Bayer
Terminated
8 enrolled